Professor Barbara Sherwin of Canada's McGill University was found having a 'ghost writer' in a paper she published as the sole author in the Journal of the American Geriatrics Society. The 'ghost writer' is hired by a drug company whose product is discussed in the paper.
After the information was revealed by a class action lawsuit against the aforementioned drug company Wyeth (now part of Pfizer), the McGill University refused to sanction Sherwin.
Professor Sherwin explained, at one point, she tried to acknowledge the ghost writer who was commissioned by the drug company, '..but she refused'.
No comments:
Post a Comment